dc.contributor.author |
Ruf, Benjamin |
|
dc.contributor.author |
Lauer, Ulrich Manfred |
|
dc.date.accessioned |
2017-11-10T14:05:58Z |
|
dc.date.available |
2017-11-10T14:05:58Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
2372-7705 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/78381 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Nature Publishing Group |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1038/mto.2015.18 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Assessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"? |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20170803141528_00487 |
|
utue.personen.roh |
Ruf, Benjamin |
|
utue.personen.roh |
Lauer, Ulrich M. |
|
dcterms.isPartOf.ZSTitelID |
Molecular Therapy - Oncolytics |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article UNSP 15018 |
de_DE |
dcterms.isPartOf.ZS-Volume |
2 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |